Ablative local therapy

DEVICE4 trials

Sponsors

University of California, Davis

Conditions

Appendiceal CancerBiliary CancerBreast CancerColorectal CancerExtrahepatic CholangiocarcinomaGall Bladder CancerHead and Neck CancerIntrahepatic Cholangiocarcinoma

Unknown Phase

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

RecruitingNCT06101290

University of California, DavisOligoprogressive, Prostate Cancer, Renal Cell Carcinoma +1

Start: 2023-12-05End: 2035-01-15Target: 150Updated: 2026-06-30

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

RecruitingNCT06101277

University of California, DavisAppendiceal Cancer, Biliary Cancer, Colorectal Cancer +5

Start: 2023-10-05End: 2039-09-15Target: 300Updated: 2026-07-02

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

RecruitingNCT06103682

University of California, DavisNon-small Cell Lung Cancer, Oligoprogressive, Small-cell Lung Cancer

Start: 2023-10-05End: 2031-09-01Target: 100Updated: 2026-07-08

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

RecruitingNCT06103669

University of California, DavisBreast Cancer, Head and Neck Cancer, Oligoprogressive +2

Start: 2023-10-05End: 2033-12-01Target: 250Updated: 2026-07-08